Data from the study shows that nearly half of the patients who received Roche's (RHHBY) subcutaneously-administered obesity drug lost more than 20% of their body weight after 24 weeks.
11 hours ago
The Wall Street Journal
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
12 hours ago
United Press International via Yahoo
Roche's experimental obesity drug shows promising early stage results
4 hours ago
Benzinga via Yahoo
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
6 hours ago
FierceBiotech
FDA approves self-collection screening tests for HPV, allowing women to avoid pelvic exams for cervical cancer
1 day ago
BioPharma Dive via Yahoo
Roche keeps pace in obesity drug field with early study data
Market Watch
Roche ramps up obesity-drug competition with early-stage trial results
Quartz
An experimental weight loss drug helped users lose 18% of their weight in an early trial
8 hours ago
Barrons.com
Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
10 hours ago
Reuters via Yahoo
Roche shares jump on obesity drug results from early-stage trial
17 hours ago
View all
Swiss healthcare company
roche.com
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Wikipedia
More on Yahoo Finance